Institute of Immunology and Virology
Institute of Immunology and Virology
News Article | February 16, 2017
Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), together with collaborators in Europe, discovered that a common type of cell within the human reproductive and intestinal tracts assists HIV in infecting immune cells. Understanding how these cells aid HIV could lead to new methods that prevent HIV transmission. The human reproductive system and intestinal tract are lined with a protective layer of cells, called the mucosa. Breaches in these layers, which can be caused by physical trauma or some sexually transmitted diseases, allow HIV to bypass the protective surface to access immune cells that can be infected by HIV. In the new study, published in PLOS Pathogens, scientists used an experimental system that models the mucosa and surrounding tissues. Surprisingly, they discovered that fibroblasts, connective tissue cells that are one of the most abundant types of cells in the mucosa, greatly increase HIV infection of immune cells. One way they do this is by transporting the virus to the body's immune cells, without themselves becoming infected, through a process called trans-infection. "We were interested in understanding how cells commonly found in mucosal tissues affect the ability of HIV to infect immune cells," explained Nadia Roan, PhD, a visiting investigator at Gladstone and assistant professor at UCSF who is the senior author of the study. "We discovered that, remarkably, mucosal fibroblasts could potently increase how well HIV infected immune cells. Knowing how this occurs at the molecular level can help us find new ways to fight the virus." The researchers examined mucosal fibroblasts from the cervix, uterus, foreskin, male urethra, and intestines--all portals of HIV entry. They found that fibroblasts from all of these tissues increased HIV infection. They did this not only by trans-infection, but also by making the immune cells more prone to infection by HIV. In future research supported by the National Institutes of Health, the researchers will study exactly how mucosal fibroblasts make immune cells more "infectable", which could ultimately lead to new targets for preventing HIV. The scientists also tested a second abundant cell type found in mucosal tissues: epithelial cells. These cells line the mucosa, where they allow helpful substances to pass through to tissues in the body and also provide a barrier against harmful substances. What the scientists discovered was that in contrast to fibroblasts, epithelial cells secrete high levels of antiviral proteins that inhibit infection. "Our work suggests that breaches in the mucosa allow HIV to bypass an antiviral environment to access fibroblasts, which in turn boost levels of HIV infection in CD4 T cells," said Warner Greene, MD, PhD, director of the Gladstone Institute of Immunology and Virology who was a senior investigator on the study. "Knowing the specific cells that allow HIV to take advantage of breaches in our defenses will enable us to find better ways to limit HIV transmission rates." Other Gladstone researchers on the study include Jason A. Neidleman, Nargis Kohgadai, and Karen S. Jang. Researchers from the University of California, San Francisco, Ulm University Medical Center (Germany), Aarhus University (Denmark), University of Alabama at Birmingham, and San Francisco General Hospital also took part in the research. Funding was provided by National Institutes of Health, the Center for AIDS Research, UCSF, the Danish Research Council, the Lundbeck Foundation, and the Bill and Melinda Gates Foundation. To ensure our work does the greatest good, the Gladstone Institutes focuses on conditions with profound medical, economic, and social impact--unsolved diseases of the brain, the heart, and the immune system. Affiliated with the University of California, San Francisco, Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease.
Grozdanovic M.M.,University of Belgrade |
Burazer L.,Institute of Immunology and Virology |
Gavrovic-Jankulovic M.,University of Belgrade
International Dairy Journal | Year: 2013
Actinidin, a cysteine protease accounting for more than 50% of the soluble proteins in kiwifruit pulp, has shown promise as a milk-clotting agent. In this study, the potential use of kiwifruit pulp extract as a clotting agent was investigated. It was shown that three kiwifruit extracts made from the pulp of a single fruit have significantly different levels of active actinidin, depending on the extraction buffer employed. Kiwifruit extract prepared at pH 5.0 had the best milk-clotting properties, with a nearly 30% better ratio of clotting activity to proteolytic activity than purified actinidin. This extract produced a casein coagulum clearly separated from the whey proteins, and was shown to be stable at room temperature for up to two months. This extract has the potential to be employed as an efficient and low-cost milk-clotting agent in the production of dairy products. © 2013 Elsevier Ltd.